Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
D
Details...
Enter Symbol
Haemonetics Corporation (NYSE: HAE)
Sector: Medical
Current Price :
$69.26
52 Week Low
$55.01
52 Week High
$72.30
Company
Overview
Research Notes
Company Profile
Competitors
Community
Wiki
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Related News
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
25M
Market Cap:
$1.80B
Avg Volume:
138050
P/E Ratio:
23.580
PEG Ratio:
1.630
Split:
On 1/11/1993 hae split by factor of 2.000
Trade now with
1m
3m
6m
1y
2y
Opinion and Analysis
Tickers For The Current Reshaping
Jan 05, 2011 10:06 AM |
AAPL
,
ABAX
,
ABC
,
ABT
,
ACAT
,
AEIS
Medical Devices Stock Review - May 2010 - Industry Outlook
May 10, 2010 05:00 PM |
BDX
,
BSX
,
CNMD
,
HAE
,
MDRX
,
MDT
On Picking Stocks And Market Corrections
Aug 26, 2009 12:52 AM |
CL
,
HAE
,
KO
,
OSK
,
PETM
,
TJX
Switching From Haemonetics (NYSE: HAE) Into Oshkosh (NYSE: OSK) "Trading Transparency"
Aug 05, 2009 09:22 AM |
BA
,
FRPT
,
GD
,
HAE
,
NAV
,
OSK
Haemonetics (HAE) : Trading Transparency
May 05, 2009 09:13 AM |
HAE
More Articles on HAE..
Market News
Haemonetics reports lower net income in Q1, provides guidance for fiscal 2012
Aug 11, 2011 05:44 AM |
HAE
More News on HAE..
Press Releases
Haemonetics Releases Next Generation of IMPACT? Online Blood Utilization Portal
May 08, 2012 08:00 AM |
HAE
Haemonetics to Present at Bank of America Merrill Lynch 2012 Health Care Conference
May 03, 2012 04:30 PM |
HAE
Haemonetics Changes Timing of Fourth Quarter and Year End Fiscal Year 2012 Webcast: April 30, 2012 at 8:00 am Eastern Time
Apr 29, 2012 12:05 PM |
HAE
More Press Releases on HAE..
SEC Filings
Form 4 HAEMONETICS CORP For: May 17 Filed by: GELBMAN RONALD G (10K)
May 21, 2012 05:07 PM
Form 4 HAEMONETICS CORP For: May 07 Filed by: MERRIMAN RONALD (10K)
May 09, 2012 05:18 PM
Form 4 HAEMONETICS CORP For: May 04 Filed by: KROLL MARK W (10K)
May 08, 2012 07:31 PM
More SEC Filings on HAE..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
HAE
Compare to S&P
YTD
16.71 %
6.91 %
4 Weeks
5.46 %
6.43 %
12 Weeks
6.51 %
5.13 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-6.98 %
EPS Growth in Last Year:
-5.88 %
Sales Growth in Last Quarter:
-2.35 %
Sales Growth in Last Quarter:
9.78 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##